Andrew McKeon

Title: The Innovative Contributions of Andrew McKeon

Introduction

Andrew McKeon is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the area of autoimmune diseases and cancer biomarkers. With a total of 6 patents to his name, McKeon's work has the potential to impact the diagnosis and treatment of serious health conditions.

Latest Patents

One of McKeon's latest patents focuses on "Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer." This disclosure describes methods and compositions for detecting the presence of a Kelch-like protein 11 autoantibody in a biological sample. It also provides methods for treating subjects with testicular cancer or a premalignant condition and paraneoplastic encephalomyelitis. Another significant patent involves "Methods and materials for identifying and treating autoimmune GFAP astrocytopathy." This document outlines methods and materials for identifying and treating this novel meningoencephalomyelitis in humans, as well as early treatment options for patients whose autoantibody profile indicates a high likelihood of underlying cancer.

Career Highlights

Throughout his career, McKeon has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Euroimmun Medizinische Labordiagnostika AG. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of McKeon's notable coworkers include Vanda A Lennon and Thomas J Kryzer. Their collaborative efforts have further advanced the understanding of autoimmune diseases and their connection to cancer.

Conclusion

Andrew McKeon's innovative work and patents are paving the way for advancements in medical diagnostics and treatment. His contributions are vital in the ongoing fight against cancer and autoimmune disorders.